Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Ansichten
• 07/13/23
0
0
Einbetten
administrator
Abonnenten
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare